Genus News and Activities

Presence

Genus develops animal genetics and biotechnology products for cattle and pigs. It provides breeding stock, genetic testing, and reproductive services to livestock farmers, breeders, and food producers.

Genus products and services overview:

Animal genetics
Cattle breeding
Pig breeding
Genetic testing
Reproductive services
Breeding stock

Revenue: ~$850 million

Employees: 3,500

Headquarters: Basingstoke, United Kingdom (UK)

Genus is one of the...

Genus is a company listed under the stock ticker GNS (GB).

Genus has a direct presence in 10 countries.

Genus has 10 subsidiaries including ABS Africa, ABS Australia and ABS Canada.

They are in:

Farming73%
Biotechnology27%

Executives

View the org chart displaying its 122 main executives

Most searched biographies at Genus

Popular executive movements at Genus

Celia Baxter will join the company as Non-Executive Director on Jan. 1, 2026 (posted on November 19 2025).

Create your alert
to follow the executive moves at Genus.

Biotechnology

Genus has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
Tissium has just announced a $60 Million fundraising (posted on July 8 2026).